Founded in 1967, Institut Supérieur de Rééducation Psychomotrice (ISRP) – Higher Institute of Psychomotor Therapy is the brainchild of Giselle Soubiran in collaboration with her son, José Soubiran.
Giselle developed the concept of psychomotor therapy (PMT) as a proper rehabilitation therapy in the 1950s while working as a physical therapist at the Henri Roussel Sainte-Anne Hospital in Paris, in the Child Psychiatry ward of Professor Julian de Ajuriaguerra, an innovative and open-minded child psychiatrist. She spent years developing a specific evaluation protocol and therapeutic plan, binding the mind and body, introducing PMT as an innovative rehabilitation technique.
As Mrs. Soubiran perfected her techniques, her son, José Soubiran, believed that the most efficient way to enable as many people as possible to benefit from this innovative approach was to open a school. Today, ISRP is the largest PMT school in the world, with three campuses in France, located in Paris, Marseille, and Vichy. The Institute has been in operation for over 50 years and has successfully trained over 7,000 psychomotor therapists in France.
In addition to being fully approved by the French Ministry of Health, ISRP offers two degrees recognized by the French State: the State Diploma of PMT (Bachelor’s level) and the Diploma of Expert in PMT (Master’s level)
Since 2014, ISRP has launched a Continuing Education Center in Shanghai and has provided PMT training to over 2000 Chinese healthcare professionals. The Center has signed multiple cooperation agreements and projects with various prestigious organisations, including the China Disabled Persons’ Federation, Chinese Association of Rehabilitation Medicine, Beijing University’s 6th Hospital, Shanghai Mental Health Center, People’s Liberation Army General Hospital, and the City Administration of Guangzhou, China.
Since its foundation, ISRP has continuously developed and trained people in rehabilitative, therapeutic, and educative psychomotricity and is now extending the knowledge and effectiveness of this unique treatment to the GCC region.